High-Yield LeukoCore™ Atopic Dermatitis Leukopaks for Immunology Research

LeukoCore™ Atopic Dermatitis Leukopak biospecimens are collected from donors clinically diagnosed with atopic dermatitis, a type of eczema, through IRB-approved apheresis procedures. Each leukopak contains large quantities of peripheral blood mononuclear cells (PBMCs), making it ideal for immune profiling, cytokine analysis, and drug development research related to atopic dermatitis, inflammation and immune dysregulation.

Product Features

• Research Use Only (RUO) human leukopak
• Clinically confirmed atopic dermatitis donors
• High cell yield for large-scale studies
• Processed and shipped within 24 hours of collection
• Fresh or cryopreserved options available
• IRB-approved and ethically sourced
• Infectious disease testing
• HLA-A typing
• Screen donors with LeukoLot™

Donor Metadata

• Verified atopic dermatitis diagnosis from healthcare providers
• Donor demographics: age, sex assigned at birth, race/ethnicity
• Self-reported medication history and allergies
• Relevant clinical data including atopic dermatitis severity (if available)

ln

• Explore our Atopic Dermatitis Donor Network

Applications

• Immune cell characterization in atopic dermatitis
• Therapeutic development and screening
• Cell-based assays and cytokine profiling
• Multi-omics studies including single-cell sequencing

Compliance and Quality Assurance

• Collected under IRB oversight with donor e-consent (21 CFR Part 11 compliant)
• HIPAA-compliant handling of donor information
• Rigorous donor screening and documentation

Ordering & Customization

Atopic Dermatitis Leukopak samples are available fresh or cryopreserved. For international shipping or regulatory documentation, please contact to confirm regional compliance and shipping availability.